Mortality cancer therapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells Neoplastic Stem Cells HT29 Cells Cell Line HeLa Cells

Organisms5

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae

Diseases39

Neoplasms Radiation Injuries Breast Neoplasms Lung Neoplasms Colonic Neoplasms Prostatic Neoplasms Ovarian Neoplasms Neoplasms, Radiation-Induced Neoplasm Metastasis Pancreatic Neoplasms Stomach Neoplasms Neoplasm Invasiveness Radiation Injuries, Experimental Carcinoma, Squamous Cell Radiation Pneumonitis Neoplasms, Experimental Carcinoma Adenocarcinoma Carcinoma, Non-Small-Cell Lung Neovascularization, Pathologic Colorectal Neoplasms Disease Progression Cell Transformation, Neoplastic Uterine Cervical Neoplasms Head and Neck Neoplasms Liver Neoplasms Urinary Bladder Neoplasms Neoplasm Recurrence, Local Brain Neoplasms Melanoma Disease Models, Animal Genetic Predisposition to Disease Skin Neoplasms Rectal Neoplasms Mammary Neoplasms, Experimental Cardiovascular Diseases Esophageal Neoplasms Occupational Diseases Bone Neoplasms

Chemicals and Drugs66

Antineoplastic Agents Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin Antibiotics, Antineoplastic Drug Carriers Neoplasm Proteins Tumor Suppressor Protein p53 Paclitaxel Radiation-Sensitizing Agents RNA, Small Interfering Camptothecin Fluorouracil Enzyme Inhibitors Etoposide Cancer Vaccines RNA, Messenger Antimetabolites, Antineoplastic Tumor Markers, Biological P-Glycoprotein Antibodies, Monoclonal Ellipticines Proto-Oncogene Proteins c-bcl-2 Protein Kinase Inhibitors DNA, Neoplasm Anticarcinogenic Agents Caspases Plant Extracts DNA-Binding Proteins Receptor, erbB-2 Caspase 3 Organoplatinum Compounds Antigens, Neoplasm Receptor, Epidermal Growth Factor Prodrugs DNA Tumor Suppressor Proteins Protein-Serine-Threonine Kinases Nanocapsules Platinum Radiation-Protective Agents Deoxycytidine Proto-Oncogene Proteins c-akt Antineoplastic Agents, Alkylating Topoisomerase I Inhibitors Taxoids Histone Deacetylase Inhibitors Daunorubicin Tamoxifen Apoptosis Regulatory Proteins Prostate-Specific Antigen DNA Topoisomerases, Type II Receptors, Estrogen Drugs, Investigational Reactive Oxygen Species Nuclear Proteins Proto-Oncogene Proteins Angiogenesis Inhibitors Vinblastine Poly(ADP-ribose) Polymerases Cell Cycle Proteins TOR Serine-Threonine Kinases Quinazolines Antineoplastic Agents, Hormonal Antibodies, Monoclonal, Humanized Mitomycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Mortality Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Hospital Mortality Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Monitoring Infant Mortality Retrospective Studies Survival Analysis Early Detection of Cancer Cause of Death Survival Rate Follow-Up Studies Combined Modality Therapy Treatment Outcome Molecular Targeted Therapy Radiotherapy Prognosis Drug Carriers Prospective Studies Neoplasm Transplantation Risk Assessment Antineoplastic Combined Chemotherapy Protocols Clinical Trials as Topic Cohort Studies Blotting, Western Models, Biological Drug Design Radiation Injuries, Experimental Transplantation, Heterologous Inhibitory Concentration 50 Radiotherapy Dosage Child Mortality Risk Tumor Burden Registries Reverse Transcriptase Polymerase Chain Reaction Neoplasms, Experimental Maternal Mortality Risk Factors Radiometry Flow Cytometry Incidence Kaplan-Meier Estimate Transfection Gene Expression Profiling Multivariate Analysis Neoplasm Staging Drug Evaluation, Preclinical Predictive Value of Tests Genetic Therapy Proportional Hazards Models Disease-Free Survival Drug Discovery Odds Ratio Radiotherapy, Adjuvant Logistic Models Sensitivity and Specificity Nanocapsules Hyperthermia, Induced Disease Models, Animal Reproducibility of Results Chemotherapy, Adjuvant Immunotherapy Gene Knockdown Techniques Oligonucleotide Array Sequence Analysis Mammary Neoplasms, Experimental Clinical Trials, Phase I as Topic Tumor Stem Cell Assay Tomography, X-Ray Computed Confidence Intervals SEER Program Drug Administration Schedule Immunohistochemistry Individualized Medicine Questionnaires

Psychiatry and Psychology1

Phenomena and Processes52

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Apoptosis Drug Resistance, Neoplasm Radiation Cell Survival Gene Expression Regulation, Neoplastic Cell Proliferation Time Factors DNA Damage Dose-Response Relationship, Drug Cell Cycle Gamma Rays Signal Transduction Cosmic Radiation Drug Synergism Inhibitory Concentration 50 Risk Mutation Cell Division Drug Resistance, Multiple DNA Repair Ultraviolet Rays Down-Regulation Transfection Background Radiation Molecular Structure Cell Death RNA Interference Cell Growth Processes Phosphorylation Odds Ratio Up-Regulation Radiation Effects Base Sequence Sensitivity and Specificity Cell Movement Genetic Predisposition to Disease Gene Expression Genes, p53 Gene Silencing Promoter Regions, Genetic Enzyme Activation X-Rays Particle Size Protein Binding DNA Methylation Tumor Microenvironment Structure-Activity Relationship Tissue Distribution

Disciplines and Occupations7

Radiation Oncology Drug Design Nanomedicine Medical Oncology Drug Discovery Immunohistochemistry Individualized Medicine

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Age Distribution Sex Distribution

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Information Science13

Mortality Hospital Mortality Infant Mortality Cause of Death Survival Rate Child Mortality Registries Maternal Mortality Incidence Molecular Sequence Data Base Sequence SEER Program Questionnaires

Named Groups2

Survivors Infant, Newborn

Health Care47

Mortality Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Hospital Mortality Radiation Monitoring Infant Mortality Retrospective Studies Survival Analysis Cause of Death Survival Rate Follow-Up Studies Treatment Outcome Prospective Studies Risk Assessment Clinical Trials as Topic Cosmic Radiation Cohort Studies Age Factors Radiation Injuries, Experimental Child Mortality Risk Registries National Cancer Institute (U.S.)Maternal Mortality Risk Factors Ultraviolet Rays Incidence Kaplan-Meier Estimate Multivariate Analysis Predictive Value of Tests Proportional Hazards Models Disease-Free Survival Odds Ratio Radiation Effects Age Distribution Logistic Models Sensitivity and Specificity Sex Factors Reproducibility of Results Clinical Trials, Phase I as Topic Confidence Intervals SEER Program Occupational Exposure Sex Distribution Questionnaires

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Mortality Neoplasms Radiation Dosage Radiation, Ionizing Cell Line, Tumor Radiation Injuries Dose-Response Relationship, Radiation Radiation Tolerance Drug Screening Assays, Antitumor Apoptosis Drug Resistance, Neoplasm Radiation Mice, Nude Breast Neoplasms Cell Survival Radiation Protection Hospital Mortality Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Monitoring Antineoplastic Agents, Phytogenic Infant Mortality Lung Neoplasms Cisplatin Doxorubicin Gene Expression Regulation, Neoplastic Cell Proliferation Colonic Neoplasms Tumor Cells, Cultured Prostatic Neoplasms Time Factors Retrospective Studies Survival Analysis Early Detection of Cancer Antibiotics, Antineoplastic Cause of Death Survival Rate Follow-Up Studies Combined Modality Therapy Treatment Outcome Radiation Oncology Ovarian Neoplasms Molecular Targeted Therapy Radiotherapy DNA Damage Prognosis Neoplasms, Radiation-Induced Drug Carriers Prospective Studies Dose-Response Relationship, Drug Cell Cycle Neoplasm Proteins Neoplasm Metastasis United States Tumor Suppressor Protein p53 Neoplasm Transplantation Paclitaxel Gamma Rays Risk Assessment Radiation-Sensitizing Agents Pancreatic Neoplasms Antineoplastic Combined Chemotherapy Protocols Signal Transduction Stomach Neoplasms Clinical Trials as Topic RNA, Small Interfering Cosmic Radiation Neoplasm Invasiveness Cohort Studies Age Factors Blotting, Western Models, Biological Drug Synergism Camptothecin Drug Design Fluorouracil Radiation Injuries, Experimental Nanoparticles Carcinoma, Squamous Cell Transplantation, Heterologous Enzyme Inhibitors Inhibitory Concentration 50 Nanomedicine Radiotherapy Dosage Radiation Pneumonitis Etoposide Child Mortality Risk Mutation Tumor Burden Registries Reverse Transcriptase Polymerase Chain Reaction Cell Division Cancer Vaccines RNA, Messenger Neoplasms, Experimental National Cancer Institute (U.S.)Carcinoma Adenocarcinoma

No FAQ available that match "mortality cancer therapy anticancer drugs or radiation"